Ovarian cancer shows considerable heterogeneity in its sensitivity to chemotherapy both clinically and in vitro. This study tested the hypothesis that the molecular basis of this difference lies ...

Gastric cancer is the top lethal cancer in Asia. As the majority of cases present with advanced disease, conventional therapies have limited efficacy. Emerging modalities provide promise to combat ...

Studying a deadly type of breast cancer called triple negative, Johns Hopkins Medicine scientists say they have identified key molecular differences between cancer cells that cling to an initial ...

HR biomarker testing is primarily done via immunohistochemistry (IHC) and detects the presence of estrogen receptors (ERs) and progesterone receptors (PRs) on cancer cells. Breast cancers that test ...

In recent decades, there has been focused research on the molecular mechanisms of cancer to improve drug delivery and survival rates.

Since the work of Paget more than 100 years ago, pathologists have recognized that the movement of cancer cells is not random and that different types of cancer have different destinations.